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Abstract
Objective: Both the National Institute of Mental Health (NIMH) and the American
Psychological Association (APA) have called upon psychodynamic practitioners to start
demonstrating their psychotherapy outcomes. This effectiveness study attempted to begin to
answer these calls. Method: The study was a secondary data analysis of existing data from
a psychodynamic mental health clinic. It used a single group, within subjects longitudinal
design. The psychometrically validated “Outcome Questionnaire” (OQ 45.2) was used as a
measure of change. A linear mixed and random effects model was used to analyze the data.
The aims of this study were: (1) to look at whether subjects improve and, (2) if so, what
variables moderate outcome. Results: Findings suggest that psychodynamic treatment is
effective over time, producing moderate effect sizes, and points to the particular importance
of the first three months in bringing about symptom change. Conclusions: Findings suggest
a common course of recovery, with some between-group variability based on several
important variables. Implications for clinical social work are discussed.
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Psychodynamic Psychotherapy: An Effectiveness Study
Most research regarding psychotherapy outcomes is done in highly controlled settings. It
uses structured, manualized treatments applied to people with a single psychiatric diagnosis.
While strong in design (i.e. providing strong internal validity), questions have been raised
about the applicability of the findings from these efficacy studies to “real life” clinical
settings. This is a concern for many clinicians, in that the majority of potential research
subjects in such efficacy studies, especially those with more than one diagnosis, are often
screened out up front (Nathan, et al., 2000). These studies have, to date, most often
evaluated the outcomes of cognitive-behavioral (i.e. CBT) interventions, as can be seen in a
review of the American Psychological Association’s Division 12 listing of empirically
supported treatments, of which only a few are psychodynamic in nature. (APA Division 12
Task Force, 1993).
The National Institute of Mental Health (NIMH Guide, 1993) and others (Gabbard,
Gunderson, & Fonagy, 2002; APA Division 12 Task Force, 1993) have lamented the lack of
empirical outcome data provided by psychodynamic therapists and have called for such
practitioners to start demonstrating their outcomes. Gabbard, Gunderson, & Fonagy (2002)
wrote recently about the threat posed to dynamic therapy by not demonstrating such
outcomes: “psychoanalytic psychotherapy is at risk of being sacrificed if scientific methods
cannot be developed that will further test its practitioners’ claims of efficacy” (p. 505).
This study was an effectiveness study: utilizing a research design with fewer controls,
done “in the field”, to begin answering this call. It looked at the outcomes of
psychodynamic psychotherapy as it is actually practiced: within an agency setting and with
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different groups of clients. It looked at how effective psychodynamic psychotherapy is and
at what its change process looks like.
Specific aims of the study: The study asked the following questions:
1.) Do clients receiving this type of treatment make significant improvement over time?
2.) If so, what variables appear to moderate its outcome?
Effectiveness research in this area has been, to date, quite limited. In the mid - 1990’s,
Consumer Reports published a study based on client self-report. That study involved
thousands of people self-reporting on their satisfaction with their own psychotherapy, but
did not look at symptom change per se. In fact, its author (Seligman, 1995) called for the
next research in this area to look beyond such self-report and to use more empirical
measures of symptom change. This study attempted to do just that.
Psychodynamic Psychotherapy Evaluation:
Psychodynamic psychotherapy is one of the most commonly practiced forms of therapy
(Vaughan, Marshall, Mackinnon, et al., 2000; Doidge, 1999; Gunderson & Gabbard, 1999;
Anderson & Lambert, 1995; Svartberg & Stiles, 1991) and yet one of the least researched.
Despite its being widely practiced, this form of therapy has historically avoided evaluation
(Gabbard & Gunderson, 2002; Sandell, et al., 2000; Doidge, 1999).

Dynamic practitioners

have historically claimed efficacy for their treatments by referring to case studies (i.e.
Wallerstein’s 42 Lives in 1986), often pointing to changes observed exclusively from the
analyst’s perspective. Others have asserted that dynamic therapy’s outcomes are beyond
measurement (i.e. involving internal, personality or “structural” change not easily or at all
able to be quantified). Still others have called their practice an art more than a science and
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thus not open to empirical evaluation (Stone, 1997). Doidge (2003) puts the sentiment of
many of his colleagues concisely: “we reject empirical outcome research” (p. 674).
This historic stance, however, is gradually changing, with psychoanalytic leaders
themselves calling for more empirical research. Freedman, et al. (1999) note,
“psychoanalysis finds itself not in a situation of crisis, but surely in one of reorganization”
(p. 741). Kernberg (1991) raises the concern that by having avoided research, “our
psychoanalytic institutes are characterized by an atmosphere of indoctrination rather than of
free scientific exploration” (p. 55). By this he means that psychoanalysis is at risk of being
taught as an ideology, as a closed system not open to the challenges or correctives scientific
inquiry might bring. In so doing, he is echoing an older criticism of psychoanalysis brought
originally by philosopher of science Karl Popper, who rejected psychoanalysis as a closed or
“circular” system not open to the scrutiny of science (Popper, 1963).
Kernberg also calls for psychoanalytic schools not to be free-standing, but to join with
universities in the spirit of holding psychoanalytic concepts up to scientific scrutiny (p. 5758) and points to the risk of the field’s “stagnation” by failing to do so (p. 61). He
ultimately hopes for the field to become more scientific: to test and to ground its assertions
in science (p. 61). He is not alone in this desire. Other leaders within psychoanalysis such
as Gabbard & Gunderson (2000) are acknowledging the need now to evaluate its outcomes
empirically (see also Sandell, 2000, Doidge, 1999; Barber & Lane, 1995).
Method
The Sample
Subjects (N = 164) were all adult outpatients in psychodynamic psychotherapy, as
offered by this psychotherapy clinic. Thirty different treating therapists were represented in

Roseborough

6

this sample. Treating therapists were primarily master-level social workers and
psychologists. Most subjects were seen for just over a year, averaging 64 sessions, though
with a large degree of variation (SD = 44.6). The total number of sessions ranged between 4
and 237 sessions. Most subjects were seen somewhere between 20 and 100 sessions,
usually with 1 time a week as the standard of care. Approximately a third (31%) of these
clients reported a planned termination, while 44% of these clients simply withdrew. 16%
ended due to their therapist’s internship ending. The rest ended for “other” reasons,
including a group ending, being referred out, or for unidentified reasons.
Clients ranged in age between 20 and 83. The mean age for a client in this sample was
38 (SD = 12.00). The majority of clients were female (60%). In keeping with national
samples, the majority were on medication at some point during their therapy. 68% utilized
medication during their therapy, while 32% did not. This is a higher percentage than the
national average of 62% (Olfson, 2002), and may be accounted for by the clinic having
psychiatrists on staff, “in house”, and by its strongly interdisciplinary model. Just under
one-half (45%) of subjects had one or more comorbid disorders, while just over half (51%)
were diagnosed with a single presenting diagnosis (4% of this data was missing). The vast
majority of these diagnoses were Axis I diagnoses (i.e. clinical syndromes), with only a
small number of people presenting with an adjustment disorder or V-Code (N = 19) or
personality disorder (N = 3) as primary diagnoses. 14 subjects (8.5%) presented, though,
with a personality disorder as part of their overall diagnosis. Initial presenting diagnoses can
be broken down according to: major depression (N = 49), dysthymia (N = 43), mood – other
(N = 19), anxiety (N = 22), adjustment disorders or V-codes (N = 19), and other (consisting
of alcohol dependence, eating disorders, etc. with N = 6).
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Clients’ initial presentations were also in keeping with national norms for adult
outpatients entering mental health settings (see comparison table below). The presenting scores
were as follows:
Insert Table 1 Here
Treatment Conditions
The setting: Hamm Memorial Psychiatric Clinic is an adult, outpatient mental health
center located in St. Paul, Minnesota. It is a multidisciplinary clinic, employing eight social
workers, five psychologists, and three psychiatrists. The clinic provides both psychodynamic
psychotherapy and medication. It does not offer medication management apart from
psychotherapy. That is, all clients receiving medication at the clinic are currently clients in
therapy at the clinic. The clinic provides clinical training for graduate level psychologists,
psychiatrists, and psychologists as well. It also provides continuing education in psychodynamic
topics for mental health practitioners in the metropolitan area.
Procedures:
Staff therapists consist of graduate level psychologists and social workers, all of whom
are educated at either a master’s or doctoral level, and all of whom have significant training and
experience in this model of psychotherapy, including through the clinic itself. Many are
graduates of the clinic’s training program and several teach the cohort of eight to 10 interns and
residents within the clinic at any given time, in addition to their practice. Treating therapists are
Caucasian (n = 10), Hispanic (n = 2), and African American ( n = 1). Most of the practitioners
are women (n = 11), while five are men. The clinic employs three psychiatrists. Clinic
administrators are clinicians themselves, and carry a case load as part of their clinic duties. The
clinic’s work is strongly cross-disciplinary. Clients are considered “clinic clients”. Social
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workers, psychologists, and psychiatrists have input into each case during weekly group
supervision.
Practitioners use an approach described by Gabbard (2000) in his book Psychodynamic
Psychiatry. This model is based on fostering a strong working alliance, the use of the therapeutic
experience as a “corrective” one, the analysis of transference, and the positive use of the therapy
relationship in general. This therapeutic relationship is seen as something which is gradually
internalized by the client. It occurs along a supportive – expressive continuum, and careful
attention is given to both resistance and to the client – therapist interaction (Gunderson &
Gabbard, 1999). The clinic draws heavily upon both (1) attachment and (2) object relations as its
core theoretical underpinnings. The clinic estimates the cost of this intervention at $ 2,645.00
per course of therapy (this estimate assumes a 23 session intervention, the clinic’s average, at a
cost of $ 115.00 per session).
Outcome Measure
Measure: The study used the OQ-45.2 (Lambert, et al., 2004; Lambert, et al., 1996).
The OQ is a 45 item client-administered questionnaire developed specifically to measure
outcomes relevant to dynamic therapy. It uses a five point scale. The OQ provides both an
overall score as well as three subscales or “domain scores”: (1) symptom distress (how the
person “feels inside”, the level of distress symptoms cause), (2) interpersonal relations (how the
person gets along with others) and (3) social role (how the person functions in terms of important
life tasks). The instrument has been normed on several community samples, including the
psychiatrically well, EAP clients, clients in outpatient mental health therapy, and with
psychiatric inpatients. It has also been tested across gender, race, and with various ethnicities. It
includes a cut-off score that differentiates normal community samples from symptomatic and
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impaired clinical samples as well as a way to calculate clinically significant change (i.e. versus a
full recovery) on all four scales. The OQ has been tested for both internal consistency and for
test-retest reliability (see Mueller, et al., 1998; Lambert, et al., 1999). It is scored by clinic staff.
It is sometimes, but not always, shared with clients. This is left to the discretion of each
individual practitioner.
Data Analysis
The statistical package SPSS 12.0 was used to perform the inferential statistical analyses. A
mixed effects model was chosen largely due to the nature of the data itself. For instance,
repeated measures ANOVA could not be performed due to the amount of missing data in earlier
clinic cases. Although most cases included a baseline, the other data points were spread out over
the course of three or more years of therapy. There was a high degree of attrition: 127 cases had
a baseline, 66 had a three month score, 64 had a six month score, 43 had a nine month score, and
only 35 had a score at 12 months. From 15 – 24 months, the number of respondents ranged
around the low 20’s at each three month interval, and only seven respondents had data points at
three or more years). Due to this degree of attrition (i.e. drop off), the decision was made to
analyze a year’s worth of data, which would be in keeping with existing studies (i.e. Kopta, et
al., 1994; Asay, et al., 2002) and offer a good basis for comparisons with existing literature.
The mixed effects model used is a regression-like approach. This approach allows the
researcher to create a trend line, which shows both (1) the direction and (2) the statistical
significance of a change. It also allows both within and between group comparisons. The model
looks for trends or changes over time, by plotting residuals. As in regression, it assumes that a
random or non-significant line is a straight and horizontal one. Time is seen as a fixed variable
and each subject at each time point (in this case, each three month interval) varies randomly.
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Non-random changes move this line up or down to significant or non-significant degrees.
Treating subjects as random effects also saves a number of degrees of freedom, and allows for
later between group comparisons.
Power Analysis
A power analysis was conducted using software from SSI.com (Congden, et al., 2001) called
“Optimal Design”, which provides a power analysis uniquely suited to: (1) a mixed model,
which (2) utilizes both repeated measures, (3) and linear, quadratic, or cubic data. This model
does so by factoring in the duration of the study, the expected effect size, the frequency and
spacing of observations, the number of subjects, and the expected degree of variation “across
persons” (Raudenbush & Xiao-Feng, 2001). It uses all of this information to create a
multidimensional power analysis (relying on vectors and matrices versus a single value the way a
unidimensional power analysis might in the case of ANOVA). Using this software and its
underlying model (see Raudenbush & Xiao-Feng, 2001), it was determined that the 164 people
in this study would provide a 72 % probability of correctly identifying significant versus nonsignificant findings (a power or d value of .72).
Results
Hypothesis 1. People will show statistically significant change between beginning
and ending this treatment.
Effect Size
The overall effect size for this treatment was found to be moderate. The effect size
for one year of treatment was calculated by subtracting the score at one year (OQTOT5) as
the “intervention mean” from the baseline OQ (OQTOT1), and dividing that number by the
baseline (OQTOT1) standard deviation. This yielded a d index of .41. This value is
squarely in the middle of a medium effect size, as defined by Lipsey, M. (1990) in a review

Roseborough 11

of over 6,700 studies on treatment effectiveness research. Similarly, an effect size was
calculated using the same approach for the first three months of treatment: which had
appeared as the only 3-month interval during which statistically significant change happened
as part of, or defining, a unique treatment period. This analysis yielded an effect size of .44.
This treatment effect was also thus moderate. The treatment effect was found to be, as
expected, moderate or “medium”. The actual strength of the effect, however (.4) was less
than anticipated and somewhat lower than the range in the existing literature, in which
estimates have ranged from .6 – 2.02. Effect sizes for each of the subscales averaged .33.
OQ Total Score
Respondents showed statistically significant change on the OQ total score (OQTOT)
between beginning and ending this treatment. The mixed effects model looked at OQ total
scores over the course of a year of treatment. OQ total scores were defined as the dependent
variable. Time was identified as a fixed factor. A high degree of correlation between the
testing periods was assumed and was factored into the model, as Lambert et al. (1996) point
to strong correlation coefficients between weeks on the OQ over a ten week period ranging
from .66 - .82 (p. 10). This assumption was also verified for this data set by running
correlations between each of the OQTOT scores at each three month interval, which
revealed correlations between OQTOT scores ranging from .312 to .875 (with most in the .5
to .7 range). The model constructed as such produced an F-value of 4.67 (210.124),
significant at p < .01, identifying OQ scores as changing significantly over time- in this case
over the course of a year. The nature of this change (in OQ total scores over a year) can be
graphed as follows:
Insert Figure 1 Here
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Change on this overall score (OQTOT) produced an effect size of .41.
OQ Symptom Distress Subscore
Statistically significant change was also made over the course of a year on the symptom
distress subscale, which produced an F value of 4.1 (211.5), sig. < .01. That is, subjects did
make symptomatic improvement over the course of a year, which was statistically
significant. This held true across gender (F=.007, (140.4), sig. = .93), and whether or not
someone had a personality disorder (F = 2.3, (142.6), p = .13. Medication did make a
difference here, with a large F [31.9 (145.02, p < .01)]. Change on this subscale produced
an effect size of .38.
OQ Interpersonal Relationships
A similar pattern held true for the interpersonal relationship (the IR) subscale.
Statistically significant change was made over the course of a year, for both genders and for
people with and without personality disorders. [IR = F 3.1 (204.7), p< .016; SR = F 2.4
(276.6), p < .05]. Change on this subscale produced an effect size of .29.
OQ Social Role Subscale
Statistically significant change was made over the course of a year, for both genders and
for people whether or not they had a personality disorder. Similarly, the presence or absence
of comorbidity did not affect outcome [F 1.450 (144.0), p = .23], while medication did [F
17.8 (155.2), p < .01]. Change on this subscale produced an overall effect size of .31.
Research Question Two: What are the variables significantly moderating
outcome?
Results for each hypothesis individually tested are given below. An alpha level of .05
was used for all statistical tests.
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Medication: Medication did exert a moderating influence in this study. Overall, people who
were medicated during treatment began as more symptomatic than those who did not use
medication. Those who were medicated tended to begin as more symptomatic and made a
quicker initial recovery (had a stronger initial slope). This difference in slope (i.e. the nature
of the recovery between the two groups), however, was not statistically significant. This
held true across diagnoses. Interaction effects were explored between medication and:
depression [F (136.2) = 1.717], anxiety [F (139.5) = .093], and adjustment disorders and Vcodes [ F (127.5) = .61]. None were found to be specific.
That is, while medication exerted a strong moderating effect, this effect was broad and
not unique to any of these three broad diagnostic groups. This is substantiated, too, by the
finding that medication accounted for only 13.8% of variance explained, when added as a
covariate and compared against “recovery in general”. Those who did not use medication
also made statistically significant change (i.e. their scores trended downward), but more
evenly and gradually.
Comorbidity: The presence or absence of a comorbid disorder did moderate outcome in this
model, when comorbidity was specified as a covariate and treated as a fixed effect. It
produced a strong effect, with an associated F-value of 4.630, (df = 133.0), and was
significant at p< .05. As might be predicted, people with comorbidity tended to begin
treatment more symptomatic than those without. They did not, however, vary significantly
in their recovery trajectory (i.e. slope) [F (200.4) = .7] from those without it.

The presence

of comorbidity accounted for only 3.9% of explained variance.
Personality Disorder: Similarly, the presence of a personality disorder did not moderate
outcome, when specified as a covariate and treated as a fixed effect [F (141.5) = 2.8]. It
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accounted for only 3.9 % of explained variance. Thus the findings in this study suggest that
while the presence or absence of comorbidity might predict a different starting point (i.e.
intercept), the presence of a personality disorder did not necessarily carry the same
prognostic or predictive power. In this study, subjects with comorbidity tended to begin
treatment more symptomatic than those without it, but followed a similar treatment recovery
path (i.e. slope) to those without it.
Demographic variables: As can be seen below, demographic variables as a group did not
tend to moderate outcome, with the exception in this study of household income. As
predicted, gender did not moderate outcome in the mixed model, when specified as a
covariate and treated as a fixed effect. It produced an F value of .01 (139.27 df). It
accounted for a negligible .006 % of explained variance. Age did not moderate outcome in
this model, when specified as a covariate and treated as a fixed effect. The model produced
an F value of 1.1 (348 df). Race did not moderate outcome in this model, when specified as
a covariate and treated at a fixed effect. The model produced an F value of 3.01 (138.7 df),
when dummy columns were created to compare “white” versus “non-white” in terms of
treatment response over time.
Household Income Household income did moderate outcome, when specified as a covariate
and treated as a fixed effect [ F (134.3) = 10.3, p < .05]. People with greater incomes began
treatment as more symptomatic than those without, though again, their treatment path
followed that of the broader clinic population. Income did not correlate significantly with
length of treatment (i.e. number of sessions) in a bivariate correlational analysis. People
with greater incomes did not tend to stay any longer (or shorter) than others in treatment.
Though statistically significant, household income itself also only accounted for 4.5% of
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explained variance when added as a covariate. There was no interaction effect between
improvement over time and income: F (197.9) = 1.24.
Education Educational level did not moderate outcome, when specified as a covariate and
treated as a fixed effect in this model. Two categories were compared. First, those who
attended college were compared with those who had not and no significant differences were
found: F = .13 (139.2). Also, those who had attended high school only were compared with
those who had pursued any form of post-secondary education. No significant differences
emerged here either [F = .32 (144.2)].
Diagnostic cluster: “Diagnostic cluster” was broken down into three diagnostic subgroups
which were compared: (1) mood disorders, (2) anxiety disorders, and (3) adjustment
disorders or V-codes (i.e. problems in living). Both mood disorders [F = 3.5 (136.4)] and
anxiety disorders [F = .53 (141.16)] failed to moderate outcome when compared against
other diagnoses. This held true as well when depression and anxiety were compared against
each other [F = .1 (59.7)]. Only adjustment disorders emerged as a cluster significantly
moderating or affecting outcome over time. People with adjustment disorders began
treatment as significantly less symptomatic than the broader clinic population (with a mean
starting OQ total score of 64.88), but followed a very similar recovery path.
Length of treatment: The length of treatment defined as the number of visits did moderate
outcome in this model when number of sessions was specified as a covariate and treated as a
fixed effect. It produced an F value of 5.4 (1, 176.3), p < .05. This took the form of a
general effect, and was not diagnosis-specific. It was also a small effect, accounting for
only 2.5% of explained variance. Similarly, no specific interactions were found between
number of sessions over time and anxiety, depression, or adjustment disorders and V-codes.
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Interestingly, those people who would stay longest in treatment began somewhat less
symptomatic than those who would end treatment earlier. The treatment path, however, had
a similar slope. There was no unique recovery path that emerged for people who stayed
longest in treatment. It thus seems that “number of sessions” exerts a significant influence,
but only insomuch as it demarcates where people begin treatment (as less symptomatic). It
does not, from these findings, predict a unique recovery pattern, a differential effect on any
particular diagnostic group, or correlate with higher or lower scores after a year of treatment.
Thus while their beginning score is unique, their treatment path and ending point, are not.
Initial symptom severity: Initial symptom severity did moderate outcome in this model,
when specified as a covariate and treated as a fixed effect. It produced a strong effect, with
an F (280.8) = 3.3, p < .05, and accounted for 57% of explained variance when added as a
covariate versus recovery in general. It was also one of the few variables which produced
not only a different intercept or starting point, but a distinctive slope that was distinct from
the general clinic population over time. Those people who began treatment with greater
symptom severity had a slower, and less consistent recovery path. This can be seen
especially in the statistically significant “bump” or increase in symptoms at time 4 (i.e. nine
months).
Interpersonal functioning at baseline did moderate outcome in this model, when specified as
a covariate and treated as a fixed effect. Interpersonal functioning in this case was
operationalized as the IR (interpersonal relationships) subscale on the OQ at baseline (time
1). An analysis of interaction effects was done between OQTOT change over time and OQ
IR (interpersonal relationship) scores at baseline. First, interpersonal functioning at baseline
did moderate outcome [F (1, 170.4) = 38.5, p < . 05], accounting for 31.8% of explained
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variance. Second, a small interaction effect was discovered which approached, but did not
reach, statistical significance: F (4, 232.7) = 2.2. This means that while those people with
poorer initial relationships (in the form of higher scores on the IR subscale at baseline)
tended to begin treatment more symptomatic (having higher OQTOT scores at baseline)
than those without such IR subscores at baseline, their recovery path (i.e. slope) was not
unique. The small uptick at time four (9 months), evident visually below, was not
statistically significant.
Discussion and Applications to Research and Practice
The findings suggest that clients receiving psychodynamic psychotherapy make both
clinically and statistically significant change over time as measured by the OQ 45.2. These
findings add evidence that this historically under-researched and widely practiced form of
psychotherapy is associated with clients reporting improved outcomes, when examined
broadly across practitioners and across heterogeneous diagnoses. It also suggests that a
common course of recovery may exist, across a large number of variables. This study adds
important information to dynamic literature in the area of moderating variables of outcome
which have been limited in previous studies. It does so within a longitudinal context and
uses an empirical measure. It also points to the importance of the first three months of
treatment. All of this is significant, in that many previous studies of psychodynamic
treatment have been criticized for lacking the above: a longitudinal component, an empirical
measure, and attention to moderating variables. This study adds to the existing literature by
responding to the limits of these previous studies.
The findings point to statistically and clinically significant change on both the OQ total
score and all three subscale scores (symptom distress, interpersonal relationships, and social
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role functioning) over time. This change held true across broad diagnostic clusters (i.e.
depression, anxiety, and adjustment), and whether or not someone had a personality
disorder. This is in keeping with existing literature that psychodynamic psychotherapy is
effective in the treatment of: depression (Leichsenring, 2001), anxiety (Svartberg, et al.,
1998), and with personality disorders (Leichsenring & Leibing, 2003).
Change over time on one particular subscale merits special attention. The OQ’s symptom
distress (SD) subscale allowed this study to speak to Seligman’s (1995) call for future
research to look at symptom change apart from clients’ self reporting on their more
subjective sense of satisfaction with therapy. Subjects in this study did make statistically
significant symptom change over time. This held true for not only the OQ total score (i.e.
overall score) but for the symptom distress subscale. The symptom distress (SD) subscale
produced an effect size of .38, the highest among the three subscales (which ranged from .28
- .38). Only the overall or OQ total score produced a stronger effect size (.41). In both cases
the majority of change occurred during the first three months. The 0 – 3 month interval in
both cases proved to be the only discrete period in which statistically significant change
occurred in relation to any other three month treatment interval.
This finding is similar to a recent finding by Lambert (2003), who points to the
importance of the first five sessions in forming an alliance and in producing some symptom
change. Lambert speaks to the need for early feedback on symptom change on the OQ,
concluding that clients do not wait for an alliance to develop or for symptom change. His
study utilized 1,020 clients and 49 therapists. Based on his findings, he concludes that (1)
“ongoing feedback leads to better outcomes” (Family Networker, 2003) and that (2)
“research tells us that clients who deteriorate in the first sessions don’t eventually get
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better...they leave therapy” (Family Networker, 2003). The finding in this study that the
most change appears to happen in the first three months of therapy substantiates Lambert’s
(2002) finding as to the importance and prognostic value of this early period. Finally, this
study’s findings also support the existing literature that suggests that demographic variables
such as gender, race, and age do not tend to moderate outcomes (i.e. Barkham, et al., 1996;
Warner, 1998, Sandell, 2000).
This study benefited from those traits associated with effectiveness studies. For instance,
the data is from a naturalistic clinic setting, and utilizes 30 different treating therapists, with
subjects (clinic clients) who come and go with a multitude of diagnoses. As can be seen in
the descriptive analysis, nearly half (44.5%) of subjects in this sample presented with more
than one diagnosis. Subjects were thus not screened out for people with single diagnoses in
the way they often are in more traditional efficacy studies. This is important because it
speaks to the potential generalizability of these findings to other clinic settings which are
often characterized by clients with similar features (comorbidity, multiple treating therapists,
etc.). Because this data collection is part of routine clinic procedures, subjects also were not
paid and did not receive extra attention for participating in a study. This in itself may soften
or minimizes any expectancy effects such as change due to a desire to please the clinician or
simply due to increased contact with providers.
A fairly uniform intervention was delivered in that this clinic provides a large amount of
weekly supervision and ongoing training that are strongly dynamic in nature. Thus, while
the study suffers from a lack of manualization or other treatment adherence measures, the
clinic’s strongly and uniquely psychodynamic identity, with its accompanying training and
supervision, may help to buffer against the lack of manualization and adherence issues. This
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impression has also borne out recently in this author’s interviews with all clinic staff about
what constitutes the treatment, which revealed a great deal of uniformity in terms of how
clinicians report they practice generally and in how they would approach treating a given
diagnosis: major depression.
Limitations include a lack of specificity, in the form of attention to individual diagnoses.
This study did look at diagnostic clusters (i.e. mood, anxiety, and adjustment disorders). It
did not look specifically at major depression or other distinct disorders. Such attention to
individual diagnoses would be a useful direction for future research to see if individual
diagnoses produce similar recovery trend lines, in studies with larger sample sizes, more
frequent measures, and more power. This analysis was limited by the number of data points
used (five). More data points would likely provide a more nuanced or detailed picture of the
nature of this change.
The amount of missing data presented a particular set of challenges and limitations. The
high degree of middle phase missing data and the infrequent measures resulted in a loss of
power. The power analysis was ex post facto or “after the fact”. See Wilkinson, L. & the
Task Force on Statistical Inference (1999) for discussions about the validity of and
alternatives to such an analysis. Some have called for not using a power analysis in this way
and for relying strictly on the confidence intervals themselves. There is not, however,
uniform agreement on this.
The possibility of expectancy and placebo effects certainly exist as additional threats to
internal validity. It is possible that clients sought to please their therapist with improving
scores over time. However, this is somewhat tempered in that support staff administered
and the OQ, it was computer scored, and at this point in the clinic’s research, the OQ was
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not formally reviewed with clients in most cases. It is possible, though, that clients would
wish to see their experience over time as positive and to thus report improved outcomes.
Placebo effects exist and are even likely. These, however, are not limited to this type of
therapy. They have been reported as a common factor in both medical and psychiatric
outcomes broadly (Benson & Starke, 1996; Hubble, Duncan, & Miller, 1999). Additional
threats include phenomena such as maturation and regression to the mean: the notion that
people often improve or simply revert to their baseline, irrespective of any treatment or
formal intervention. This is especially as risk in a time series design such as this, as
Campbell & Stanley (1963) note.
The next steps for research in this area are related. They include: the use of empirical
measures such as the OQ, at more frequent intervals (monthly measures), and with less
missing data. This would allow for greater power, a more detailed picture of what this
change looks like over time, and closer comparisons with existing literature on recovery
trends (Lambert, 2003). Future comparisons and replications would be aided by researchers
using a common or shared battery of measures ( McCullough, in Miller, Luborsky, and
Barber, 1993). This would allow studies using the OQ to compare results with studies using
the OQ versus comparing the OQ to instruments such as the Social Adjustment Scale (SAS).
Future studies would also benefit from the use of treatment fidelity measures. While
supervision and a fairly theoretically homogenous approach was used in this study, future
studies would benefit from an even better defined treatment such as the use of either or both:
(1) a psychodynamic treatment manual, and (2) measures of fidelity to the treatment itself.
This could be done through supervision during the study itself or thorough independent
assessors rating the degree of adherence via video or audio tape. If the above could be done
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in relation to particular diagnoses, the design would be especially strong, reaping the
benefits of both (1) effectiveness research in a naturalistic setting, with (2) tighter design
contros. This would also speak to remaining questions in the literature as to which
treatments are best for which people, with which diagnoses.
This study lends support for a more brief and focused dynamic treatment as the treatment
of choice, broadly. Of course, other literature exists speaking to the length of treatment as
being diagnosis-specific. Whereas diagnoses such as borderline personality disorder
(Linehan, 1993 ; Beck, 1990) often call for longer term treatments (i.e. greater than a year),
this study lends support to the idea that for more acute diagnoses, a time limited dynamic
therapy can be effective. This is a finding in line with both Strupp & Binder (1984) and
with the American Psychological Association’s list of empirically supported treatments,
both of which discuss brief or time-limited dynamic therapies with good research behind
them. Agencies, too, can use these convergent findings to inform their own internal policy
decisions as to how they think about limiting or dispensing therapy as a resource.
Lastly, the findings from this study have several implications for how
psychodynamic theory is conceptualized. First, psychodynamic theory has often historically
claimed its authority by way of attributed authority. It has stayed in the realm of theory,
without its tenets being empirically tested (Stone, 1997). This study, which utilized an
empirical measure, lends weight to the claim that dynamic therapy is effective, when tested.
Second, the finding that the most significant change (on all OQ scales) happens within the
first three months of a year-long therapy points to the idea of an initial therapeutic window.
This finding has several important implications itself. Not only does it point to the
importance of initial improvement, but it challenges the psychodynamic idea that people
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need to get worse before they get better. That is, in this study, improvement happens up
front, versus later. This challenges the idea of an incubation theory, in which change is
hypothesized to begin later in or even after the therapy ends. A quantitative study by Huber,
Klug, & von Rad (2002) reached a similar conclusion (they did not find evidence for an
incubation period in dynamic therapy).
The idea that “longer is better” is also not necessarily supported in that while length of
treatment did moderate outcome in this study, it did so by affecting where clients began
treatment on the OQ versus how they recovered. No interaction effects were found between
length of treatment and improvement at time 5 (one year of treatment). This may argue for a
more targeted, briefer intervention.
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Table 1: OQ Sample Scores in Relation to National Norms
Clinic’s Mean

National Mean

OQ Total

82.09

83.09

OQ Symptom Distress

47.62

49.40

OQ Interpersonal Relationship

20.09

19.68

OQ Social Role

14.46

14.01
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Figure 1: Overall Change
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